$NTRA News

Natera: Even 30% Annual Growth Through 2030 Doesn't Support $310 Per Share

Here's How Much $1000 Invested In Natera 10 Years Ago Would Be Worth Today

Citigroup Maintains Buy on Natera, Raises Price Target to $365

Natera, Inc. (NTRA) Presents at Canaccord Genuity's 46th Annual Growth Conference Transcript

Piper Sandler Maintains Overweight on Natera, Raises Price Target to $363.5

Stephens & Co. Maintains Overweight on Natera, Raises Price Target to $350

Guggenheim Maintains Buy on Natera, Raises Price Target to $360

Natera Announces New Collaboration Regarding Phase 1 Clinical Trial, Sponsored By Kupando Therapeutics

TD Cowen Maintains Buy on Natera, Raises Price Target to $340

Citigroup Maintains Buy on Natera, Raises Price Target to $315

RBC Capital Maintains Outperform on Natera, Raises Price Target to $350

Natera CEO Says Company Is 'Clearly on a Roll' After Record Test Volumes, Raises Outlook

JP Morgan Maintains Overweight on Natera, Raises Price Target to $360

Wells Fargo Maintains Equal-Weight on Natera, Raises Price Target to $284

Evercore ISI Group Maintains Outperform on Natera, Raises Price Target to $360

BTIG Maintains Buy on Natera, Raises Price Target to $320

Natera (NASDAQ:NTRA) Beats Q2 Estimates, Raises Full-Year Revenue Guidance

Natera, Inc. (NTRA) Q2 2026 Earnings Call Transcript

Natera, Inc. 2026 Q2 - Results - Earnings Call Presentation

Natera Raises FY2026 Sales Guidance from $2.740B-$2.820B to $2.850B-$2.910B vs $2.797B Est